(Q42626017)
Statements
Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia (English)
Malcolm Mitchell
Prajakti Kothare
Richard Bergstrom
Fangyi Zhao
Kai Yu Jen
Daniel Walker
31 October 2013